Skip to content

Asfotase alfa

Strensiq (asfotase alfa) is an enzyme pharmaceutical. Asfotase alfa was first approved as Strensiq on 2015-08-28. It is used to treat hypophosphatasia in the USA. It has been approved in Europe to treat hypophosphatasia.
Trade Name Strensiq
Common Name Asfotase alfa
Indication hypophosphatasia
Drug Class Enzymes
Asfotase alfa
Get full access now